AdvisorShares Investments LLC Has $215,000 Stake in Enveric Biosciences, Inc. (NASDAQ:ENVB)

AdvisorShares Investments LLC increased its stake in shares of Enveric Biosciences, Inc. (NASDAQ:ENVB) by 63.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 599,854 shares of the company’s stock after purchasing an additional 232,807 shares during the quarter. AdvisorShares Investments LLC owned approximately 88.21% of Enveric Biosciences worth $215,000 as of its most recent filing with the SEC.

Enveric Biosciences Stock Up 0.7 %

Shares of ENVB opened at $1.36 on Wednesday. Enveric Biosciences, Inc. has a 12 month low of $1.01 and a 12 month high of $15.45. The company’s fifty day moving average is $1.54 and its 200-day moving average is $3.89. The firm has a market cap of $3.36 million, a price-to-earnings ratio of -0.04 and a beta of 0.65.

Analysts Set New Price Targets

Separately, HC Wainwright restated a “buy” rating and set a $10.00 price target on shares of Enveric Biosciences in a report on Thursday, March 6th.

About Enveric Biosciences

Enveric Biosciences, Inc, a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health.